| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.03 |